Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered unattainable.

Fatty liver disease—now known in medical terms as metabolic dysfunction‑associated steatotic liver disease (MASLD)—is on the rise, especially among people who are overweight, diabetic, or have ...

At the Liver Meeting sponsored by the American Association for the Study of Liver Diseases, investigators presented new ...

In November 2025, Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology firm specializing in therapies for primary ...

Experts say Claude had extensive liver cancer with evidence of liver failure. Katelyn Jonozzo lived a very active lifestyle ...

AMSTERDAM, the Netherlands — For patients with unresectable intermediate-stage hepatocellular carcinoma, selective internal radioembolization and standard transarterial chemoembolization provide ...